tirzepatide cause death linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s Does Tirzepatide Cause Birth Defects?

What is your specific goal

Warning: Do not use if pregnant or breast feeding, elderly, under the age of 18 or if safety seal is broken

Sources Lilly investor news Eli Lilly FDA drug approval process FDA.gov Related reading Retatrutide Phase 3 Results 2026: TRIUMPH Trial Tracker Living tracker of every retatrutide trial TRIUMPH-1/2/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts

Retail versus compounded fulfillment A prescription may route to a retail pharmacy for an FDA-approved brand tirzepatide product or to a licensed 503A pharmacy for a compounded preparation, which is not an FDA-approved finished drug product